Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02490800 | Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma | ||
| NCT03138733 | Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia | ||
| NCT02527681 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | ||
| NCT05582187 | A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function. | ||
| NCT00529282 | A Study of Ceftobiprole in Patients With Fever and Neutropenia. | ||
| NCT01657890 | Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects | ||
| NCT01635946 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin | ||
| NCT00412893 | Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis | ||
| NCT01597986 | Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone | ||
| NCT04098692 | Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects | ||
| NCT02059590 | A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects | ||
| NCT01582412 | Drug Interaction Study of Isavuconazole and Digoxin | ||
| NCT01245140 | Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis | ||
| NCT00124436 | Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis | ||
| NCT04804059 | A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males | ||
| NCT02128893 | A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole | ||
| NCT02956499 | Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects | ||
| NCT00210964 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT06925321 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. | ||
| NCT04148287 | An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris | ||
| NCT01026636 | A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age | ||
| NCT02957929 | Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally | ||
| NCT01711827 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects | ||
| NCT01026558 | A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | ||
| NCT04243863 | VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers | ||
| NCT05856227 | Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age | ||
| NCT04240886 | Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds | ||
| NCT01030731 | Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease | ||
| NCT01809860 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects | ||
| NCT06961708 | A Study of Fosmanogepix in Healthy Adult Chinese Subjects | ||
| NCT06665555 | Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age | ||
| NCT02128321 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine | ||
| NCT04087876 | Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | ||
| NCT00965042 | Effect of Ceftobiprole on Human Intestinal Microflora | ||
| NCT00413439 | Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | ||
| NCT00771719 | Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia | ||
| NCT03241550 | A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | ||
| NCT05527834 | Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants | ||
| NCT04045613 | Derazantinib and Atezolizumab in Patients With Urothelial Cancer | ||
| NCT00413218 | Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections | ||
| NCT03604705 | An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia | ||
| NCT04604132 | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma | ||
| NCT00326287 | Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia | ||
| NCT04166669 | A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 | ||
| NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT04314206 | VNRX-5024 Safety and PK in Healthy Adult Volunteers | ||
| NCT05421858 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | ||
| NCT01651325 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects | ||
| NCT01397929 | An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors | ||
| NCT06733675 | Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination |
